Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AB 206

Known as: AB-206, AB206 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Objective To evaluate the effect and safety of trigonal injection of botulinum toxin A (BTX-A) for patients with neurological… Expand
Is this relevant?
2015
2015
Objective To research the expression of CCAT2 in renal cell carcinoma (RCC), bladder cancer and paired normal tumor-adjacent… Expand
Is this relevant?
2014
2014
To examine whether urinary tract nerve growth factor (uNGF) could be a biomarker for overactive bladder (OAB) symptom, we… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
To examine whether urinary tract nerve growth factor (uNGF) could be a biomarker for overactive bladder (OAB) symptom, we… Expand
Is this relevant?
1980
1980
A new chemotherapeutic agent, AB206, shows potent antibacterial activity against gram-negative bacteria, including most of the… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
1980
1980
AB206 (5,8-dihydro-5-methoxy-8-oxo-2H-1,3-dioxolo-4,5-g quinoline 7-carboxylic acid) is a novel antibacterial agent structurally… Expand
  • table 1
  • figure 2
  • table 2
  • table 3
  • figure 4
Is this relevant?